Extra-CNS metastasis from glioblastoma: A rare clinical entity

Musaddiq Awan; Stanley Liu; Arjun Sahgal; Sunit Das; Samuel T. Chao; Eric L. Chang; Jonathan P.S. Knisely; Kristin Redmond; Jason W. Sohn; Mitchell Machtay; Andrew E. Sloan; David B. Mansur; Lisa R. Rogers; Simon S. Lo

doi:10.1586/14737140.2015.1028374

Extra-CNS metastasis from glioblastoma: A rare clinical entity

Musaddiq Awan, Stanley Liu, Arjun Sahgal, Sunit Das, Samuel T. Chao, Eric L. Chang, Jonathan P.S. Knisely, Kristin Redmond, Jason W. Sohn, Mitchell Machtay, Andrew E. Sloan, David B. Mansur, Lisa R. Rogers, Simon S. Lo

Research output: Contribution to journal › Review article › peer-review

19 Scopus citations

Abstract

Extra-CNS metastasis from glioblastoma (ECMGBM) is an emerging but little known clinical entity. We review pre-clinical and translational publications assessing the ability of GBM to spread locally and outside the CNS. Reported cases demonstrating ECMGBM are reviewed providing a summary of presentations for the entity. Special attention is placed on transmission of GBM through organ transplantation. Finally, predictions are made as to the future significance of ECMGBM, especially in the context of better outcomes in CNS GBM.

Original language	English (US)
Pages (from-to)	545-552
Number of pages	8
Journal	Expert Review of Anticancer Therapy
Volume	15
Issue number	5
DOIs	https://doi.org/10.1586/14737140.2015.1028374
State	Published - May 1 2015

All Science Journal Classification (ASJC) codes

Oncology
Pharmacology (medical)

Access to Document

10.1586/14737140.2015.1028374

Cite this

@article{c7fd0d7575a242b2aff013623b1b3aa4,

title = "Extra-CNS metastasis from glioblastoma: A rare clinical entity",

abstract = "Extra-CNS metastasis from glioblastoma (ECMGBM) is an emerging but little known clinical entity. We review pre-clinical and translational publications assessing the ability of GBM to spread locally and outside the CNS. Reported cases demonstrating ECMGBM are reviewed providing a summary of presentations for the entity. Special attention is placed on transmission of GBM through organ transplantation. Finally, predictions are made as to the future significance of ECMGBM, especially in the context of better outcomes in CNS GBM.",

author = "Musaddiq Awan and Stanley Liu and Arjun Sahgal and Sunit Das and Chao, {Samuel T.} and Chang, {Eric L.} and Knisely, {Jonathan P.S.} and Kristin Redmond and Sohn, {Jason W.} and Mitchell Machtay and Sloan, {Andrew E.} and Mansur, {David B.} and Rogers, {Lisa R.} and Lo, {Simon S.}",

note = "Publisher Copyright: {\textcopyright} 2015 Informa UK, Ltd.",

year = "2015",

month = may,

day = "1",

doi = "10.1586/14737140.2015.1028374",

language = "English (US)",

volume = "15",

pages = "545--552",

journal = "Expert Review of Anticancer Therapy",

issn = "1473-7140",

publisher = "Expert Reviews Ltd.",

number = "5",

}

TY - JOUR

T1 - Extra-CNS metastasis from glioblastoma

T2 - A rare clinical entity

AU - Awan, Musaddiq

AU - Liu, Stanley

AU - Sahgal, Arjun

AU - Das, Sunit

AU - Chao, Samuel T.

AU - Chang, Eric L.

AU - Knisely, Jonathan P.S.

AU - Redmond, Kristin

AU - Sohn, Jason W.

AU - Machtay, Mitchell

AU - Sloan, Andrew E.

AU - Mansur, David B.

AU - Rogers, Lisa R.

AU - Lo, Simon S.

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Extra-CNS metastasis from glioblastoma (ECMGBM) is an emerging but little known clinical entity. We review pre-clinical and translational publications assessing the ability of GBM to spread locally and outside the CNS. Reported cases demonstrating ECMGBM are reviewed providing a summary of presentations for the entity. Special attention is placed on transmission of GBM through organ transplantation. Finally, predictions are made as to the future significance of ECMGBM, especially in the context of better outcomes in CNS GBM.

AB - Extra-CNS metastasis from glioblastoma (ECMGBM) is an emerging but little known clinical entity. We review pre-clinical and translational publications assessing the ability of GBM to spread locally and outside the CNS. Reported cases demonstrating ECMGBM are reviewed providing a summary of presentations for the entity. Special attention is placed on transmission of GBM through organ transplantation. Finally, predictions are made as to the future significance of ECMGBM, especially in the context of better outcomes in CNS GBM.

UR - http://www.scopus.com/inward/record.url?scp=84928605897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928605897&partnerID=8YFLogxK

U2 - 10.1586/14737140.2015.1028374

DO - 10.1586/14737140.2015.1028374

M3 - Review article

C2 - 25907706

AN - SCOPUS:84928605897

SN - 1473-7140

VL - 15

SP - 545

EP - 552

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

IS - 5

ER -

Extra-CNS metastasis from glioblastoma: A rare clinical entity

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this